171 related articles for article (PubMed ID: 3525075)
1. Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.
Hurteloup P; Ganzina F
Drugs Exp Clin Res; 1986; 12(1-3):233-46. PubMed ID: 3525075
[TBL] [Abstract][Full Text] [Related]
2. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
Wadler S; Fuks JZ; Wiernik PH
J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of new anthracyclines].
Robert J
Bull Cancer; 1988; 75(2):167-74. PubMed ID: 3282579
[TBL] [Abstract][Full Text] [Related]
4. New anthracycline analogs in advanced breast cancer.
Bonfante V; Ferrari L; Brambilla C; Rossi A; Villani F; Crippa F; Valagussa P; Bonadonna G
Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1379-85. PubMed ID: 3470179
[TBL] [Abstract][Full Text] [Related]
5. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
6. Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.
Arcamone F
Cancer Res; 1985 Dec; 45(12 Pt 1):5995-9. PubMed ID: 3864526
[TBL] [Abstract][Full Text] [Related]
7. [New anthracyclines in the treatment of solid tumors in the advanced stage].
Pannuti F; Martoni A; Lelli G; Camaggi CM; Strocchi E; Fruet F
G Ital Chemioter; 1985; 32(1):49-56. PubMed ID: 3868636
[No Abstract] [Full Text] [Related]
8. Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes.
Le Bot MA; Bégué JM; Kernaleguen D; Robert J; Ratanasavanh D; Airiau J; Riché C; Guillouzo A
Biochem Pharmacol; 1988 Oct; 37(20):3877-87. PubMed ID: 3190734
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline analogs: the past, present, and future.
Weiss RB; Sarosy G; Clagett-Carr K; Russo M; Leyland-Jones B
Cancer Chemother Pharmacol; 1986; 18(3):185-97. PubMed ID: 2948729
[No Abstract] [Full Text] [Related]
10. [Current status of clinical results of new antitumor drugs].
Ogawa M
Gan To Kagaku Ryoho; 1985 Feb; 12(2):179-88. PubMed ID: 3918502
[TBL] [Abstract][Full Text] [Related]
11. [A phase I trial of idarubicin by oral administration].
Ogawa M; Kimura K; Taguchi T; Wakui A; Hattori M; Shimoyama T; Fujita H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1896-900. PubMed ID: 3473981
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of idarubicin administered i.v. to pediatric patients with acute lymphoblastic leukemia.
Madon E; Grazia G; De Bernardi B; Comelli A; Carli M; Sainati L; Paolucci G; Canino R; Colella R; Bagnulo S
Cancer Treat Rep; 1987 Sep; 71(9):855-6. PubMed ID: 3476202
[TBL] [Abstract][Full Text] [Related]
13. The anthracyclines: will we ever find a better doxorubicin?
Weiss RB
Semin Oncol; 1992 Dec; 19(6):670-86. PubMed ID: 1462166
[TBL] [Abstract][Full Text] [Related]
14. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
[No Abstract] [Full Text] [Related]
15. DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs.
Spadari S; Pedrali-Noy G; Focher F; Montecucco A; Bordoni T; Geroni C; Giuliani FC; Ventrella G; Arcamone F; Ciarrocchi G
Anticancer Res; 1986; 6(5):935-40. PubMed ID: 3026237
[TBL] [Abstract][Full Text] [Related]
16. New anthracycline antitumor antibiotics.
Muggia FM; Green MD
Crit Rev Oncol Hematol; 1991; 11(1):43-64. PubMed ID: 1831987
[TBL] [Abstract][Full Text] [Related]
17. Idarubicin: an evaluation of cardiac toxicity in 77 patients with solid tumors.
Bertelli G; Amoroso D; Pronzato P; Rosso R
Anticancer Res; 1988; 8(4):645-6. PubMed ID: 3178154
[TBL] [Abstract][Full Text] [Related]
18. Reduction of oxygen uptake in vitro as an index of cardiac toxicity induced by new anthracyclines.
Cini-Neri G; Neri B
Anticancer Res; 1986; 6(2):195-7. PubMed ID: 3458425
[TBL] [Abstract][Full Text] [Related]
19. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
Warrell RP
Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
[TBL] [Abstract][Full Text] [Related]
20. Idarubicin in advanced breast cancer: a phase II study.
Lionetto R; Pronzato P; Conte PF; Sertoli MR; Amoroso D; Rosso R
Cancer Treat Rep; 1986 Dec; 70(12):1439-40. PubMed ID: 3466694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
